Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
The pharmaceutical industry, particularly Pharmacy Benefit Managers (PBMs), is under scrutiny for deceptive business practices that prioritize profits over patient care. Mark Cuban highlights five ways PBMs harm U.S. healthcare and suggests solutions. Cuban also comments on the reluctance of weight-loss drug manufacturers to sell through certain channels, prompting further investigation into the pharmacy business.
This is how bad the pharmacy business is https://t.co/KwkRlpQdW0
We asked @mcuban why Ozempic and other weight-loss drug manufacturers won't sell through @costplusdrugs. "I can only guess," he wrote. "You should ask them." So, naturally, we did exactly that: https://t.co/kGCznB4Oq2 https://t.co/iSOgRXMJi4
Shark Tank’s Mark Cuban speaks out on Ozempic, weight-loss drugs https://t.co/6FQUyJa5qW
